Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Jasper Therapeutics, Inc.

NASDAQ: JSPR · Life Sciences · 11 alerts · CIK 1788028

Share price
$11.77Close, Nov 16
Market cap
$13.1M
Shares outstanding
1.11MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Jasper Therapeutics, Inc. filings on SEC EDGAR ↗

8:00 AM ET 8-K
Clinical Trial Data

Jasper Therapeutics Clinical Trial Data

Jasper Therapeutics completed enrollment for the IgA nephropathy (IgAN) cohort of its Phase 2 basket study evaluating vensobafusp alfa (KP104). The company expects to report initial interim data from this study by year-end 2026 and plans to expand the study to include patients with focal segmental glomerulosclerosis (FSGS) in early 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.